Repositioning For Allosteric Modulation of VIP and PACAP Receptors

Langer I, Latek D. Drug . Front Endocrinol (Lausanne). 2021 Nov 18;12:711906. doi: 10.3389/fendo.2021.711906. eCollection 2021.

Previous
Previous

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Next
Next

Involvement of chemerin and CMKLR1 in the progesterone decrease by PCOS granulosa cells